^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
iC9.GD2.CAR.IL-15 T-cells
i
Other names: iC9.GD2.CAR.IL-15 T-cells, autologous iC9-GD2CAR-CD28-CD3zeta-IL-15-expressing T-lymphocytes, autologous ic9-gd2car-cd28-cd3zeta-il-15-expressing T-cells, iC9-GD2. CAR.IL-15 T, Autologous Activated T-Cells Expressing a 2nd Generation GD2 Chimeric Antigen Receptor, IL-15, and iCaspase9 Safety Switch, CAR T-Cells Targeting the GD2 With IL-15+iCaspase9
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
UNC Lineberger Comprehensive Cancer Center
Drug class:
IL-15R stimulant, GD2-targeted CAR-T immunotherapy
Related drugs:
